Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004352 (
autism
)
32,579
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
T-Brain-1
(
TBR1
), a causative gene in
autism
spectrum disorders (ASDs), encodes a brain-specific T-box transcription factor. It is therefore possible that
TBR1
controls the expression of other
autism
risk factors. The downstream genes of
TBR1
have been identified using microarray and promoter analyses. In this study, we annotated individual genes downstream of
TBR1
and investigated any associations with ASDs through extensive literature searches. Of 124
TBR1
target genes, 23 were reported to be associated with ASDs. In addition, one gene, Kiaa0319, is a known causative gene for dyslexia, a disorder frequently associated with
autism
. A change in expression level in 10 of these 24 genes has been previously confirmed. We further validated the alteration of RNA expression levels of Kiaa0319, Baiap2, and Gad1 in Tbr1 deficient mice. Among these 24 genes, four transcription factors Auts2, Nfia, Nr4a2, and Sox5 were found, suggesting that
TBR1
controls a transcriptional cascade relevant to
autism
pathogenesis. A further five of the 24 genes (Cd44, Cdh8, Cntn6, Gpc6, and Ntng1) encode membrane proteins that regulate cell adhesion and axonal outgrowth. These genes likely contribute to the role of
TBR1
in regulation of neuronal migration and axonal extension. Besides, decreases in Grin2b expression and increases in Gad1 expression imply that neuronal activity may be aberrant in Tbr1 deficient mice. These analyses provide direction for future experiments to reveal the pathogenic mechanism of
autism
.
Autism
Res 2015 Aug
PMID:T-Brain-1--A Potential Master Regulator in Autism Spectrum Disorders. 2560 67